Bell Asset Management Ltd Reduces Holdings in Masimo Co. (MASI)
Bell Asset Management Ltd lessened its stake in shares of Masimo Co. (NASDAQ:MASI) by 34.4% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 30,030 shares of the medical equipment provider’s stock after selling 15,756 shares during the period. Bell Asset Management Ltd owned 0.06% of Masimo worth $4,153,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in MASI. Vanguard Group Inc. raised its position in shares of Masimo by 2.7% during the 3rd quarter. Vanguard Group Inc. now owns 4,147,708 shares of the medical equipment provider’s stock valued at $516,556,000 after buying an additional 109,065 shares in the last quarter. Vanguard Group Inc raised its position in shares of Masimo by 2.7% during the 3rd quarter. Vanguard Group Inc now owns 4,147,708 shares of the medical equipment provider’s stock valued at $516,556,000 after buying an additional 109,065 shares in the last quarter. FMR LLC raised its position in shares of Masimo by 17.8% during the 4th quarter. FMR LLC now owns 3,889,562 shares of the medical equipment provider’s stock valued at $417,622,000 after buying an additional 587,587 shares in the last quarter. MERIAN GLOBAL INVESTORS UK Ltd raised its position in shares of Masimo by 12.6% during the 4th quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 779,500 shares of the medical equipment provider’s stock valued at $83,694,000 after buying an additional 87,476 shares in the last quarter. Finally, Victory Capital Management Inc. raised its position in shares of Masimo by 13.3% during the 4th quarter. Victory Capital Management Inc. now owns 726,329 shares of the medical equipment provider’s stock valued at $77,986,000 after buying an additional 85,255 shares in the last quarter. 83.80% of the stock is owned by institutional investors and hedge funds.
Several analysts have recently issued reports on MASI shares. Needham & Company LLC restated a “buy” rating on shares of Masimo in a research report on Tuesday. BidaskClub lowered shares of Masimo from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 20th. Zacks Investment Research raised shares of Masimo from a “sell” rating to a “hold” rating in a research report on Wednesday, January 23rd. Finally, Piper Jaffray Companies reissued an “overweight” rating and issued a $140.00 price objective on shares of Masimo in a research report on Wednesday, February 27th. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $132.00.
Shares of NASDAQ MASI traded up $0.19 during midday trading on Thursday, reaching $135.33. 2,423 shares of the company’s stock traded hands, compared to its average volume of 418,646. Masimo Co. has a one year low of $84.46 and a one year high of $141.05. The company has a market cap of $7.18 billion, a PE ratio of 44.69, a P/E/G ratio of 2.79 and a beta of 1.19.
Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, February 26th. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.72 by $0.11. Masimo had a net margin of 22.55% and a return on equity of 19.53%. The firm had revenue of $223.10 million for the quarter, compared to the consensus estimate of $220.96 million. During the same period last year, the firm earned $0.72 earnings per share. The company’s quarterly revenue was up 7.3% on a year-over-year basis. As a group, equities research analysts expect that Masimo Co. will post 3.08 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: This article was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/bell-asset-management-ltd-reduces-holdings-in-masimo-co-masi/2955294.html.
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Recommended Story: What are gap-down stocks?
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.